Evaluating the Expected Costs and Budget Impact of Interventional Therapies for the Treatment of Chronic Venous Disease.

Carlton, Rashad; Mallick, Rajiv; Campbell, Chelsey; Raju, Aditya; O'Donnell, Thomas; Eaddy, Michael

Carlton, Rashad; Mallick, Rajiv; Campbell, Chelsey; Raju, Aditya; O'Donnell, Thomas; Eaddy, Michael.

Affiliation

Carlton R; Dr Carlton is Associate Director, Xcenda, Palm Harbor, FL.
Mallick R; Dr Mallick is Senior Director, BTG International, West Conshohocken, PA.
Campbell C; Dr Campbell is Manager, Xcenda, Palm Harbor, FL.
Raju A; Mr Raju is Manager, Xcenda, Palm Harbor, FL.
O'Donnell T; Dr O'Donnell is Benjamin Andrews Chair of Surgery Emeritus, Tufts Medical Center, Boston, MA.
Eaddy M; Dr Eaddy is Vice President, Xcenda, Palm Harbor, FL.

Am Health Drug Benefits ; 8(7): 366-74, 2015 Oct.

Article de En | MEDLINE | ID: mdl-26557230

Mots clés

budget impact model; chronic venous disease; endovenous laser ablation; multimodality treatment; polidocanol injectable foam; radiofrequency ablation; varicose veins

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Health_economic_evaluation Langue: En Journal: Am Health Drug Benefits Année: 2015 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google